Salesforce, Inc. Website

Salesforce, Inc.

NYSE-CRM

Basic

  • Market Cap

    $248.57B

  • EV

    $244.29B

  • Shares Out

    969M

  • Revenue

    $35.74B

  • Employees

    72,682

Margins

  • Gross

    76%

  • EBITDA

    25.74%

  • Operating

    18.45%

  • Pre-Tax

    18.16%

  • Net

    15.3%

  • FCF

    31.71%

Returns (5Yr Avg)

  • ROA

    2.78%

  • ROTA

    5.08%

  • ROE

    4.45%

  • ROCE

    2.74%

  • ROIC

    1.75%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $300.19

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $17.67B

  • Net Debt

    -$4,278M

  • Debt/Equity

    0.22

  • EBIT/Interest

    227.34

Growth (CAGR)

  • Rev 3Yr

    16.94%

  • Rev 5Yr

    20.6%

  • Rev 10Yr

    23.29%

  • Dil EPS 3Yr

    5.47%

  • Dil EPS 5Yr

    30.59%

  • Dil EPS 10Yr

    29.09%

  • Rev Fwd 2Yr

    8.97%

  • EBITDA Fwd 2Yr

    8.98%

  • EPS Fwd 2Yr

    15.74%

  • EPS LT Growth Est

    18.04%

Dividends

  • Yield

    —

  • Payout

    7.1%

  • DPS

    $0.4

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Jan '15

Jan '16

Jan '17

Jan '18

Jan '19

Jan '20

Jan '21

Jan '22

Jan '23

Jan '24

LTM

Jan '25 (E)

Jan '26 (E)

Jan '27 (E)

Metric
Jan '15
Jan '16
Jan '17
Jan '18
Jan '19
Jan '20
Jan '21
Jan '22
Jan '23
Jan '24
LTM

Total Revenues

17,098

21,252

26,492

31,352

34,857

35,743

Total Revenues % Chg.

28.7%

24.3%

24.7%

18.3%

11.2%

11%

Cost of Goods Sold, Total

4,235

5,438

7,026

8,360

8,541

8,578

Gross Profit

12,863

15,814

19,466

22,992

26,316

27,165

Selling General & Admin Expenses, Total

9,634

11,761

14,453

16,079

15,411

15,505

R&D Expenses

2,766

3,598

4,465

5,055

4,906

5,067

Other Operating Expenses, Total

12,400

15,359

18,918

21,134

20,317

20,572

Operating Income

463

455

548

1,858

5,999

6,593

Interest Expense, Total

—

—

—

-110

—

-10

-29

-29

Interest And Investment Income

—

—

—

—

—

—

—

Net Interest Expenses

—

—

-110

—

-10

-29

-29

Currency Exchange Gains (Loss)

—

—

—

—

—

—

—

Other Non Operating Income (Expenses)

-18

46

-227

-121

245

311

EBT, Excl. Unusual Items

445

391

321

1,727

6,215

6,875

Restructuring Charges

—

—

—

—

—

—

—

—

-828

-988

-285

Gain (Loss) On Sale Of Investments

—

—

427

2,170

1,211

-239

-277

-99

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

—

—

—

Other Unusual Items

—

—

—

-166

—

—

—

—

—

EBT, Incl. Unusual Items

706

2,561

1,532

660

4,950

6,491

Income Tax Expense

580

-1,511

88

452

814

1,021

Earnings From Continuing Operations

126

4,072

1,444

208

4,136

5,470

Net Income

126

4,072

1,444

208

4,136

5,470

Net Income to Common Incl Extra Items

126

4,072

1,444

208

4,136

5,470

Net Income to Common Excl. Extra Items

126

4,072

1,444

208

4,136

5,470

Total Shares Outstanding

893

919

989

981

971

971

Weighted Avg. Shares Outstanding

829

908

955

992

974

971.5

Weighted Avg. Shares Outstanding Dil

850

930

974

997

984

983.3

EPS

0.2

4.5

1.5

0.2

4.2

5.6

EPS Diluted

0.2

4.4

1.5

0.2

4.2

5.6

EBITDA

2,598

3,301

3,846

5,644

9,221

9,202

Effective Tax Rate

82.2%

-59%

5.7%

68.5%

16.4%

15.7%